Voluntary Reporting Best for Identifying Pediatric ADEs
Clinicians typically use medical chart review, voluntary reporting, or computerized adverse drug event (ADE) surveillance to identify pediatric ADEs; however, an Agency for Healthcare Reporting and Quality (AHRQ) Sept. 8 press release says a new study found that surveillance did not detect ADEs in children as well as in adults.
The best way to detecting pediatric ADEs is with voluntary reporting in tandem with targeted chart review and computerized surveillance, conclude Jeffrey Ferranti, M.D., M.S., and Duke University colleagues. They found voluntary reporting efficiently identifies administration errors, while chart and computerized surveillance excells at detecting ADEs caused by high-risk medications and identifying evolving conditions that may provoke imminent patient harm.
For more information, read “Reevaluating the Safety Profile of Pediatrics: A Comparison of Computerized Adverse Drug Event Surveillance and Voluntary Reporting in the Pediatric Environment,” by Dr. Ferranti, Monica M. Horvath, Ph.D., Heidi Cozart, R.Ph., and others, in the May 2008 Pediatrics 121, pp. e1201-e1207.